Oncolytic Virus Improves Progression-Free Survival in Pancreatic Cancer
Theriva Biologics’ VCN-01, an oncolytic virus therapy for advanced pancreatic cancer, showed mixed results in a Phase IIb trial published in Nature.
Theriva Biologics’ VCN-01, an oncolytic virus therapy for advanced pancreatic cancer, showed mixed results in a Phase IIb trial published in Nature.
New study links ultra-processed foods to higher heart disease risks, analyzing 8.8M adults and tracking outcomes over decades.
Long-term air pollution exposure linked to higher mental and physical illness rates, study finds.
Theriva Biologics’ VCN-01, an oncolytic virus therapy for advanced pancreatic cancer, showed mixed results in a Phase IIb…
Squint may indicate serious eye conditions like cataracts and strabismus. Learn warning signs early to protect vision health…
AI tool ChromAgeNet identifies aging in blood stem cells by analyzing chromatin structure, helping researchers study cellular aging…